Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Ellen 't Hoen
45 POSTS
0 COMMENTS
http://medicineslawandpolicy.org
The elephant in the room at the WHO Executive Board
Ellen 't Hoen
-
January 22, 2021
Some Surprises in the European Commission’s New Intellectual Property Strategy
Ellen 't Hoen
-
December 2, 2020
Dutch Court Orders AstraZeneca to Pay Damages in Patent Evergreening Case
Ellen 't Hoen
-
October 14, 2020
WTO Members discuss proposal to suspend certain intellectual property protection during the Covid-19 crisis
Ellen 't Hoen
-
October 14, 2020
TRIPS Council to discuss IP and the public interest in the context of Covid-19
Ellen 't Hoen
-
July 29, 2020
Remdesivir developed country price announced
Ellen 't Hoen
-
June 30, 2020
The € 7.4 billion for Covid-19 product and vaccine development needs a few strings...
Ellen 't Hoen
-
May 5, 2020
Covid-19 intellectual property pool gaining support
Ellen 't Hoen
-
April 23, 2020
Covid-19 and the comeback of compulsory licensing
Ellen 't Hoen
-
March 23, 2020
The Expanding Reach of the European Patent Office. Good for Health?
Ellen 't Hoen
-
March 18, 2020
1
2
3
...
5
Page 1 of 5